Standard care therapy

OTHER2 trials

Sponsors

Max Healthcare Insititute Limited, Hospital Universitario Infanta Leonor

Conditions

COVID 19COVID-19

Phase 2

Assess the Safety and Efficacy of Convalescent Plasma to Limit COVID-19 Associated Complications

Max Healthcare Insititute LimitedCOVID 19

Start: 2020-05-09End: 2021-08-09Updated: 2020-07-22

Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19).

TerminatedNCT04441385

Hospital Universitario Infanta LeonorCOVID-19

Start: 2020-06-26End: 2021-02-08Updated: 2022-03-11